B-cell-specific IRF4 deletion accelerates chronic lymphocytic leukemia develo-pment by enhanced tumor immune evasion.

Asslaber, D; Qi, Y; Maeding, N; Steiner, M; Denk, U; Hopner, JP; Hartmann, TN; Zaborsky, N; Greil, R; Egle, A.

Blood. 2019 Nov 14;134(20):1717-1729. doi: 10.1182/blood.2019000973.

https://pubmed.ncbi.nlm.nih.gov/31537531/